Screener
Kopin KOPN Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| ASC Six Zero Six Revenues | $9.86M+16.7% | $6.78M-35.7% | —— | —— | $8.45M-32.8% | |
| Collaboration | $271.48K+172% | $329.61K+230% | $99.75K— | $99.75K— | $99.75K— | |
| Defense | $7.31M+17.5% | $5.31M-37.2% | $4.74M-61.0% | $9.93M-4.8% | $6.22M-40.4% | |
| Grant | $2.6M+1,111% | $3.44M+1,505% | $214.5K— | $214.5K— | $214.5K— | |
| Industrial | $20.4K-98.0% | $64.16K-83.6% | $853K+169% | $749K+53.2% | $1.03M+67.6% | |
| License And Royalties | $56K+15.4% | $64.93K-9.7% | $221K-46.6% | $69K-46.5% | $48.54K-56.7% | |
| Medical | $309.34K+45.0% | —— | $20K-22.3% | $1K-96.1% | $213.38K+729% | |
| Net Product Revenue | $7.64M+1.9% | $5.42M-41.2% | —— | —— | $7.5M-31.2% | |
| Non ASC Six Zero Six Revenues | $2.87M+813% | $3.77M+1,100% | $314.25K— | $314.25K— | $314.25K— | |
| Research And Development | $2.17M+139% | $1.29M+4.3% | $1.25M-25.0% | $1.2M-47.1% | $907.91K-22.4% | |
| Revenue by Geography | ||||||
| Asia Pacific | $56K-52.8% | $70.97K-72.5% | $500K+40.1% | $278K-27.2% | $118.66K-79.5% | |
| Europe | $351.63K+170% | $359.6K+65.5% | $477K+482% | $137K-58.0% | $130.05K-35.6% | |
| US | $12.33M+50.6% | $10.07M+0.2% | $7.36M-48.2% | $11.55M-8.4% | $8.18M-29.2% |
FAQ
- How does Kopin break its business down?
- Kopin (KOPN) reports revenue by product across 12 parts — ASC Six Zero Six Revenues, Collaboration, Consumer And Other Product, Defense and Grant. Each is extracted from the segment footnotes and tracked over time.
- Where does Kopin's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Kopin's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
